JPH1081664A5 - - Google Patents

Info

Publication number
JPH1081664A5
JPH1081664A5 JP1997138227A JP13822797A JPH1081664A5 JP H1081664 A5 JPH1081664 A5 JP H1081664A5 JP 1997138227 A JP1997138227 A JP 1997138227A JP 13822797 A JP13822797 A JP 13822797A JP H1081664 A5 JPH1081664 A5 JP H1081664A5
Authority
JP
Japan
Prior art keywords
carbon atoms
alkyl
group
independently
perfluoroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997138227A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1081664A (ja
JP4039588B2 (ja
Filing date
Publication date
Priority claimed from DE19621483A external-priority patent/DE19621483A1/de
Application filed filed Critical
Publication of JPH1081664A publication Critical patent/JPH1081664A/ja
Publication of JPH1081664A5 publication Critical patent/JPH1081664A5/ja
Application granted granted Critical
Publication of JP4039588B2 publication Critical patent/JP4039588B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP13822797A 1996-05-29 1997-05-28 置換された２−ナフトイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬 Expired - Fee Related JP4039588B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19621483A DE19621483A1 (de) 1996-05-29 1996-05-29 Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621483:1 1996-05-29

Publications (3)

Publication Number Publication Date
JPH1081664A JPH1081664A (ja) 1998-03-31
JPH1081664A5 true JPH1081664A5 (enExample) 2005-04-07
JP4039588B2 JP4039588B2 (ja) 2008-01-30

Family

ID=7795549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13822797A Expired - Fee Related JP4039588B2 (ja) 1996-05-29 1997-05-28 置換された２−ナフトイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬

Country Status (29)

Country Link
US (1) US6087304A (enExample)
EP (1) EP0810206B1 (enExample)
JP (1) JP4039588B2 (enExample)
KR (1) KR970074776A (enExample)
CN (1) CN1167759A (enExample)
AR (1) AR008373A1 (enExample)
AT (1) ATE198320T1 (enExample)
AU (1) AU710065B2 (enExample)
BR (1) BR9703338A (enExample)
CA (1) CA2206366C (enExample)
CZ (1) CZ163097A3 (enExample)
DE (2) DE19621483A1 (enExample)
DK (1) DK0810206T3 (enExample)
ES (1) ES2154002T3 (enExample)
GR (1) GR3035126T3 (enExample)
HR (1) HRP970292B1 (enExample)
HU (1) HUP9700955A3 (enExample)
ID (1) ID16989A (enExample)
IL (1) IL120924A (enExample)
NO (1) NO308527B1 (enExample)
NZ (1) NZ314915A (enExample)
PL (1) PL185754B1 (enExample)
PT (1) PT810206E (enExample)
RU (1) RU2190600C2 (enExample)
SI (1) SI0810206T1 (enExample)
SK (1) SK282020B6 (enExample)
TR (1) TR199700428A2 (enExample)
TW (1) TW416944B (enExample)
ZA (1) ZA974665B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621482A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
AR039156A1 (es) * 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
CA2566526C (en) * 2004-06-02 2012-10-23 F. Hoffmann-La Roche Ag Naphthaline derivatives useful as histamine-3-receptor ligands
TW200614995A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
AU2013205388B2 (en) * 2005-06-24 2016-05-05 Biotron Limited Antiviral compounds and methods
PT2826770T (pt) * 2005-06-24 2018-12-18 Biotron Ltd Compostos acilguanidinas com atividade antiviral
EP2069302B1 (en) * 2006-09-15 2010-08-25 Pfizer Inc. Substituted pyridylmethyl bicyclocarboxyamide compounds
EP2394987A4 (en) * 2009-02-09 2012-09-05 Astellas Pharma Inc ACYLGUANIDINDERIVAT
JPWO2010090305A1 (ja) * 2009-02-09 2012-08-09 アステラス製薬株式会社 置換アシルグアニジン誘導体
TW201116281A (en) * 2009-08-06 2011-05-16 Astellas Pharma Inc N atom containing ring acylguanidine derivatives
PL2671869T3 (pl) 2011-02-02 2016-09-30 Pochodna tetrahydroizochinoliny
WO2026008867A1 (en) * 2024-07-04 2026-01-08 Institut National de la Santé et de la Recherche Médicale Novel inhibitors of acsl4 and their use as medicines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251545A (en) * 1979-09-19 1981-02-17 Gaf Corporation Fungicidal process using 1-(alkoxyaroyl)guanidines
IT1238227B (it) * 1989-12-01 1993-07-12 Modulo di smistamento per impianti di convogliamento a nastro e simili
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4415873A1 (de) * 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JPH08225513A (ja) * 1994-12-21 1996-09-03 Kanebo Ltd ナフトイルグアニジン誘導体
DE19621482A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Similar Documents

Publication Publication Date Title
JPH10109970A5 (enExample)
JP2006512301A5 (enExample)
JP2006515585A5 (enExample)
JPS60209559A (ja) 置換スルホンアミドベンズアミド及びその製法
KR970025611A (ko) 치환된 설폰이미다미드, 이의 제조방법,약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
KR970074776A (ko) 치환된 2-나프토일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
JP2025505200A5 (enExample)
JP2023538524A5 (enExample)
KR960000861A (ko) 퍼플루오로알킬 그룹을 갖는 페닐-치환된 알케닐카보구아니디드, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
FR2629457A1 (fr) Imidazoles substitues en positions 2, 3, 4, et 1, 2, 4-triazoles substitues en positions 3, 4, 5, leur preparation et leur utilisation
RU97109003A (ru) Замещенные 2-нафтоилгуанидины, способ их получения и лекарственное средство на их основе
KR880011082A (ko) β-아미노 에틸-치환된 페닐 화합물 및 그들의 약제학적으로 허용되는 염 및 아미드
JPH02500029A (ja) アリール‐ｎ‐アミノアルキル‐４‐（スルホンアミド）ベンズアミド、抗不整脈剤及びその組成物
RU2008119465A (ru) Производные циклопропилуксусной кислоты и их применение
JPH0226629B2 (enExample)
JPH1081663A5 (enExample)
RU2002118700A (ru) Замещенные производные норборниламина, способ их получения, их применение в качестве медикаментов или диагностических средств, а также содержащие их медикаменты
JP2008519783A5 (enExample)
JPH1129545A5 (enExample)
JPH03112971A (ja) 心臓血管作用薬としての３，４，５，６―テトラヒドロ―２ｈ―１，７，４―ベンゾジオキサゾニン
KR970074753A (ko) 치환된 1-나프토일구아니딘, 이의 제조 방법, 약물과 진단제로서의 이의 용도 및 이를 함유하는 약제
RU97113146A (ru) Замещенные инданилидинацетилгуанидины, способ их получения, применение в качестве лекарственных или диагностических средств и лекарственные средства, содержащие эти соединения
DK150902B (da) Analogifremgangsmaade til fremstilling af n-(3-alkylaminopropyl)-n'-(disubstitueret)-phenylurinstoffer
KR970006282A (ko) 4-플루오로알킬-치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도, 및 이를 포함하는 약제
JPH1067731A5 (enExample)